A Head-to-Head Comparison of the Postprandial Effects of 3 Meal Replacement Beverages Among People With Type 2 Diabetes

被引:3
|
作者
Fonda, Stephanie J. [1 ]
Jain, Asha [2 ]
Vigersky, Robert A. [1 ]
机构
[1] Gen Internal Med Serv, Walter Reed Army Med Ctr, Endocrinol Clin, Dept Med, Washington, DC USA
[2] Gen Internal Med Serv, Walter Reed Army Med Ctr, Wellness Serv, Washington, DC USA
来源
DIABETES EDUCATOR | 2010年 / 36卷 / 05期
关键词
WEIGHT-LOSS; GLUCOSE; MANAGEMENT; DIET; FOOD;
D O I
10.1177/0145721710378537
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Purpose The purpose of this study was to compare the effects of 3 meal replacement beverages on glycemic response among people with type 2 diabetes. Methods The study examined Glucerna (R) Weight Loss Shake, Slim-Fast (R) Shake, and Ensure (R) with Fiber Shake, using a prospective, 3-way, cross-over design. Eighteen subjects with type 2 diabetes drank the beverages in random order on different weeks. The volume of each beverage was adjusted to include 50 grams of carbohydrates. Glucose was measured 0 to 180 minutes postprandial. Analyses included 2-factor analysis of variance (ANOVA) for repeated measures on both factors, calculation of area under the curve (AUC), and 1-way repeated measures ANOVA of AUC. Results The postprandial glucose profiles of the shakes differed. Glucerna (R) had the best profile as indicated by the graph of mean postprandial glucose levels and its lower incremental AUC. Despite the superiority of Glucerna (R), 2-hour postprandial blood glucose values exceeded the ADA's recommended upper limit for 22% of the subjects. Conclusions Meal replacement beverages are a popular and potentially effective option for people trying to lose or maintain weight; however, it is unknown to what degrees they affect postprandial blood glucose in people with type 2 diabetes. Because postprandial glycemic excursion is linked to cardiovascular disease, identifying a meal replacement beverage with the lowest glycemic response may mitigate some of the risks in patients with diabetes. Of the meal replacements observed in this study, Glucerna (R) had the smallest effect on postprandial glucose. Glycemic response to meal replacements should be monitored given product and individual variability.
引用
收藏
页码:793 / 800
页数:8
相关论文
共 50 条
  • [1] A Head-To-Head Comparison of Benzbromarone and Allopurinol on the Risk of Type 2 Diabetes Mellitus in People With Asymptomatic Hyperuricemia
    Lai, Shih-Wei
    Liao, Kuan-Fu
    Kuo, Yu-Hung
    Lin, Cheng-Li
    Liu, Chiu-Shong
    Hwang, Bing-Fang
    FRONTIERS IN PHARMACOLOGY, 2021, 12
  • [2] A head-to-head comparison of personal and professional continuous glucose monitoring systems in people with type 1 diabetes: Hypoglycaemia remains the weak spot
    Moser, Othmar
    Pandis, Marlene
    Aberer, Felix
    Kojzar, Harald
    Hochfellner, Daniel
    Elsayed, Hesham
    Motschnig, Melanie
    Augustin, Thomas
    Kreuzer, Philipp
    Pieber, Thomas R.
    Sourij, Harald
    Mader, Julia K.
    DIABETES OBESITY & METABOLISM, 2019, 21 (04): : 1043 - 1048
  • [3] Prospective head-to-head comparison of non-invasive scores for diagnosis of fibrotic MASH in patients with type 2 diabetes
    Castera, Laurent
    Garteiser, Philippe
    Laouenan, Cedric
    Vidal-Trecan, Tiphaine
    Vallet-Pichard, Anais
    Manchon, Pauline
    Paradis, Valerie
    Czernichow, Sebastien
    Roulot, Dominique
    Larger, Etienne
    Pol, Stanislas
    Bedossa, Pierre
    Correas, Jean-Michel
    Valla, Dominique
    Gautier, Jean-Francois
    Van Beers, Bernard E.
    JOURNAL OF HEPATOLOGY, 2024, 81 (02) : 195 - 206
  • [4] HEAD-TO-HEAD COMPARISON OF TWO ALGORITHMS ADJUSTING MEAL-TIME INSULIN DOSES BASED ON CGM TREND ARROWS IN PATIENTS WITH TYPE 1 DIABETES
    Di Molfetta, S.
    Parise, M.
    Fiorentino, R.
    Cutruzzola, A.
    Irace, C.
    DIABETES TECHNOLOGY & THERAPEUTICS, 2023, 25 : A147 - A148
  • [5] Head-to-head comparison between flash and continuous glucose monitoring systems in outpatients with type 1 diabetes
    Bonora, B.
    Maran, A.
    Ciciliot, S.
    Avogaro, A.
    Fadini, G. P.
    JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION, 2016, 39 (12): : 1391 - 1399
  • [6] Head-to-head comparison between flash and continuous glucose monitoring systems in outpatients with type 1 diabetes
    B. Bonora
    A. Maran
    S. Ciciliot
    A. Avogaro
    G. P. Fadini
    Journal of Endocrinological Investigation, 2016, 39 : 1391 - 1399
  • [7] A Head-to-Head Trial of Metformin Extended and Immediate-Release in Patients with Type 2 Diabetes
    Aggarwal, Naresh
    Singla, Anuj
    Mathieu, Chantal
    Montanya, Eduard
    Pfeiffer, Andreas F. H.
    Johnsson, Eva
    Zhao, June
    Iqbal, Nayyar
    Bailey, Clifford
    DIABETES, 2017, 66 : A326 - A327
  • [8] IN SILICO HEAD-TO-HEAD COMPARISON OF INSULIN GLARGINE 300 U/ML AND INSULIN DEGLUDEC IN TYPE 1 DIABETES
    Visentin, R.
    Schiavon, M.
    Giegerich, C.
    Sieber, J.
    Man, C. Dalla
    Cobelli, C.
    Klabunde, T.
    DIABETES TECHNOLOGY & THERAPEUTICS, 2018, 20 : A18 - A18
  • [9] DPP-4 inhibitors in the management of type 2 diabetes: A critical review of head-to-head trials
    Scheen, A. J.
    DIABETES & METABOLISM, 2012, 38 (02) : 89 - 101
  • [10] Combined lipid goal attainment in patients with type 2 diabetes and dyslipidemia: A head-to-head comparative trial of statins
    Wu, Tsung-Hui
    Lee, I-Te
    Ho, Low-Tone
    Sheu, Wayne H-H
    Hwu, Chii-Min
    JOURNAL OF THE CHINESE MEDICAL ASSOCIATION, 2022, 85 (08) : 831 - 838